Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBD Drip is a California-based consumer health company specializing in the production and distribution of hemp-derived cannabidiol (CBD) products. Founded in 2014 and headquartered in Newport Beach, the company gained prominence for its high-potency 'Official Vape Additive' line, which includes the Gold, Platinum, and Onyx concentrations. In December 2018, CBD Drip was acquired by Ecosciences, a publicly traded company focused on the wellness and environmental sectors. The company's product portfolio features full-spectrum CBD extracts available in various formats, including tinctures, capsules, and topicals, all designed to support general wellness, pain management, and anxiety relief. CBD Drip emphasizes quality through rigorous third-party lab testing and the use of non-GMO industrial hemp.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBD Drip.